Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 2Phase 3 2Phase 2 1

Status

Unknown 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Recurrence 1Motor Activity 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Diet × Clear all
NCT03971019 2019-08-14

SBSBC

Peking Union Medical College Hospital

Phase 3 Unknown
314 enrolled
Breast

Breast Neoplasms

NCT02035631 2014-01-14

PREDICOP

Institut Català d'Oncologia

Phase 3 Unknown
2,000 enrolled
Breast

Breast Neoplasms, Motor Activity, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡